The role and regulation of the NKG2D/NKG2D ligand system in cancer

G Tan, KM Spillane, J Maher - Biology, 2023 - mdpi.com
Simple Summary The immune system provides surveillance measures to identify and
remove damaged cell types at an early stage. One important example involves the NKG2D …

Innovative breakthroughs facilitated by single-cell multi-omics: manipulating natural killer cell functionality correlates with a novel subcategory of melanoma cells

Z Zhao, Y Ding, LJ Tran, G Chai, L Lin - Frontiers in immunology, 2023 - frontiersin.org
Background Melanoma is typically regarded as the most dangerous form of skin cancer.
Although surgical removal of in situ lesions can be used to effectively treat metastatic …

Application of CRISPR screen in mechanistic studies of tumor development, tumor drug resistance, and tumor immunotherapy

M Li, J Sun, G Shi - Frontiers in Cell and Developmental Biology, 2023 - frontiersin.org
Tumor is one of the biggest threats to human health. Though tumor therapy has been
dramatically advanced by the progress of technology and research in recent decades, it is …

A neutrophil mimicking metal-porphyrin-based nanodevice loaded with porcine pancreatic elastase for cancer therapy

T Cui, Y Zhang, G Qin, Y Wei, J Yang, Y Huang… - Nature …, 2023 - nature.com
Precise discrimination and eradication of cancer cells by immune cells independent of
antigen recognition is promising for solid tumor therapeutics, yet remains a tremendous …

Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma

J Liu, L Xing, J Li, K Wen, N Liu, Y Liu, G Wu… - Nature …, 2024 - nature.com
Anti-CD38 monoclonal antibodies like Daratumumab (Dara) are effective in multiple
myeloma (MM); however, drug resistance ultimately occurs and the mechanisms behind this …

NF-κB signaling pathway in tumor microenvironment

Y Cao, Y Yi, C Han, B Shi - Frontiers in Immunology, 2024 - frontiersin.org
The genesis and progression of tumors are multifaceted processes influenced by genetic
mutations within the tumor cells and the dynamic interplay with their surrounding milieu …

Identification of genetic modifiers enhancing B7-H3-targeting CAR T cell therapy against glioblastoma through large-scale CRISPRi screening

X Li, S Sun, W Zhang, Z Liang, Y Fang, T Sun… - Journal of Experimental …, 2024 - Springer
Background Glioblastoma multiforme (GBM) is a highly aggressive brain tumor with a poor
prognosis. Current treatment options are limited and often ineffective. CAR T cell therapy …

[HTML][HTML] Insights of immune cell heterogeneity, tumor-initiated subtype transformation, drug resistance, treatment and detecting technologies in glioma …

T Chen, W Ma, X Wang, Q Ye, X Hou, Y Wang… - Journal of Advanced …, 2024 - Elsevier
Background With the gradual understanding of glioma development and the immune
microenvironment, many immune cells have been discovered. Despite the growing …

[HTML][HTML] Advancements in CRISPR screens for the development of cancer immunotherapy strategies

YR Li, Z Lyu, Y Tian, Y Fang, Y Zhu, Y Chen… - Molecular Therapy …, 2023 - cell.com
CRISPR screen technology enables systematic and scalable interrogation of gene function
by using the CRISPR-Cas9 system to perturb gene expression. In the field of cancer …

Deletion of the TMEM30A gene enables leukemic cell evasion of NK cell cytotoxicity

L Kristenson, C Badami, A Ljungberg… - Proceedings of the …, 2024 - National Acad Sciences
Natural killer (NK) cell immunotherapy has gained attention as a promising strategy for
treatment of various malignancies. In this study, we used a genome-wide CRISPR screen to …